Shanghai Pharmaceuticals

Shanghai Pharmaceuticals is one of the...

• CSI 300;
• Forbes Global 2000 (#833);
• Global Fortune 500 (#438).

Shanghai Pharmaceuticals is a company listed under the stock ticker 601607 (CN).

View the org chart displaying its 16 main executives

Most searched biographies at Shanghai Pharmaceuticals

• Cho Man, Executive Director and President
• Wang Zhong, Independent Director
• Zhaoyang Gu, Independent Non-Executive Director

Popular executive movements at Shanghai Pharmaceuticals

• Yao Jiayong, who was Vice Chairman and Non-Executive Director, is promoted to Interim Chairman of the Board and Vice Chairman of the Board  (posted on November 20 2023).
• Zhou Jun, Chairman and Non-Executive Director, has left the company  (posted on November 20 2023).

Create your alert
to follow the executive moves at Shanghai Pharmaceuticals.

Shanghai Pharmaceuticals has 1,863 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Shanghai Pharmaceuticals

Social media about Shanghai Pharmaceuticals

• Shanghai Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Shanghai Pharmaceuticals on LinkedIn, Twitter & YouTube

Contact by email its executives including Dongming Li

Call Shanghai Pharmaceuticals at +86 216...

View the org chart

Register to receive your alert

Report an error